• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗安全。

Vaccine Safety.

机构信息

Department of Family & Community Medicine, University of Missouri, MA303 School of Medicine, One Hospital Drive, Columbia, MO 65212, USA.

Department of Family & Community Medicine, University of Missouri, MA303 School of Medicine, One Hospital Drive, Columbia, MO 65212, USA.

出版信息

Prim Care. 2020 Sep;47(3):431-441. doi: 10.1016/j.pop.2020.04.001. Epub 2020 Apr 22.

DOI:10.1016/j.pop.2020.04.001
PMID:32718441
Abstract

The details of vaccine development, licensing, and monitoring have never been more important and relevant to the health care conversation in the United States. The potential exists for a preventive medicine such as a vaccine to cause harm, and physicians and patients need to understand the real balance of risks and benefits of immunization. Vaccines given in the United States undergo rigorous testing before licensure as well as extensive postlicensure safety monitoring.

摘要

疫苗研发、许可和监测的细节从未像现在这样对美国的医疗保健对话如此重要和相关。像疫苗这样的预防医学有可能造成伤害,医生和患者需要了解免疫接种的真正风险和收益平衡。在美国,疫苗在获得许可之前要经过严格的测试,并且在获得许可后还要进行广泛的安全性监测。

相似文献

1
Vaccine Safety.疫苗安全。
Prim Care. 2020 Sep;47(3):431-441. doi: 10.1016/j.pop.2020.04.001. Epub 2020 Apr 22.
2
Vaccination policies and programs: the federal government's role in making the system work.疫苗接种政策与计划:联邦政府在确保该体系有效运作中的作用。
Prim Care. 2001 Dec;28(4):697-711, v. doi: 10.1016/s0095-4543(05)70037-3.
3
Challenges in evaluating post-licensure vaccine safety: observations from the Centers for Disease Control and Prevention.评估疫苗上市后安全性面临的挑战:来自疾病预防控制中心的观察。
Expert Rev Vaccines. 2019 Oct;18(10):1091-1101. doi: 10.1080/14760584.2019.1676154. Epub 2019 Oct 19.
4
Re: "A Vaccine Study Design Selection Framework for the Postlicensure Rapid Immunization Safety Monitoring Program".关于:“用于上市后快速免疫接种安全监测计划的疫苗研究设计选择框架”。
Am J Epidemiol. 2016 Jan 15;183(2):167. doi: 10.1093/aje/kwv314. Epub 2015 Dec 18.
5
Vaccine adverse event reporting: the importance of follow-up.疫苗不良事件报告:随访的重要性。
Expert Rev Vaccines. 2005 Aug;4(4):445-8. doi: 10.1586/14760584.4.4.445.
6
Current status and future directions of post-marketing vaccine safety monitoring with focus on USA and Europe.以美国和欧洲为重点的疫苗上市后安全性监测的现状与未来方向
Biologicals. 2012 Sep;40(5):393-7. doi: 10.1016/j.biologicals.2012.07.007. Epub 2012 Aug 17.
7
A vaccine study design selection framework for the postlicensure rapid immunization safety monitoring program.疫苗上市后快速免疫安全性监测计划的研究设计选择框架。
Am J Epidemiol. 2015 Apr 15;181(8):608-18. doi: 10.1093/aje/kwu322. Epub 2015 Mar 13.
8
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.免疫接种后安全性监测:疫苗不良事件报告系统(VAERS)——美国,1991 - 2001年
MMWR Surveill Summ. 2003 Jan 24;52(1):1-24.
9
Enhancing vaccine safety capacity globally: A lifecycle perspective.从生命周期角度提升全球疫苗安全能力。
Vaccine. 2015 Nov 27;33 Suppl 4(0 4):D46-54. doi: 10.1016/j.vaccine.2015.06.073. Epub 2015 Oct 1.
10
Post-licensure rapid immunization safety monitoring program (PRISM) data characterization.疫苗上市后快速免疫安全性监测项目(PRISM)数据特征描述。
Vaccine. 2013 Dec 30;31 Suppl 10:K98-112. doi: 10.1016/j.vaccine.2013.04.088.

引用本文的文献

1
Evidence-based policies in public health to address COVID-19 vaccine hesitancy.公共卫生领域中应对新冠疫苗犹豫问题的循证政策。
Future Virol. 2023 Mar. doi: 10.2217/fvl-2022-0028. Epub 2023 Apr 4.
2
Allergic Reactions to Vaccines in Children: From Constituents to Specific Vaccines.儿童疫苗过敏反应:从成分到特定疫苗
Biomedicines. 2023 Feb 18;11(2):620. doi: 10.3390/biomedicines11020620.
3
Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives.疫苗与过敏反应:过去、当前的 COVID-19 大流行及未来展望。
Allergy. 2021 Jun;76(6):1640-1660. doi: 10.1111/all.14840. Epub 2021 Jun 4.